Live Breaking News & Updates on Therapeutics Reports Full Year

Stay updated with breaking news from Therapeutics reports full year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation. ....

Lily-ramsey , Absci-corporation , Integrated-drug-creation , Therapeutics , Iopharmaceutical , Hronic , Ermatology , Drug-discovery , Kin ,

We Might See A Profit From Arovella Therapeutics Limited (ASX:ALA) Soon

With the business potentially at an important milestone, we thought we'd take a closer look at Arovella Therapeutics. ....

Management-team , Arovella-therapeutics , Arovella-therapeutic , Simply-wall , Track-record , High-performing-stocks , Therapeutics , Australian-pharmaceuticals , Biotechnology-company ,

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Earnings Haven't Escaped The Attention Of Investors

Axsome Therapeutics, Inc.'s ( NASDAQ:AXSM ) price-to-sales (or "P/S") ratio of 19.3x may look like a poor investment. ....

Axsome-therapeutics , Axsome-therapeutic , Therapeutics , Hare-price ,

When Will BiVictriX Therapeutics Plc (LON:BVX) Become Profitable?

We feel now is a pretty good time to analyse BiVictriX Therapeutics Plc's ( LON:BVX ) business as it appears the. ....

Management-team , Bivictrix-therapeutics , Bivictrix-therapeutic , Simply-wall , Track-record , High-performing-stocks , Therapeutics , Biotechnology-company ,

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics

Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics 30-Aug-2023 / 22:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solel. ....

Gibraltar , Montenegro , Kosovo , Albania , Secheron , Switzerland-general , Switzerland , United-kingdom , Monaco , Liechtenstein , Monza , Lombardia